Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
25.28
+0.09 (0.36%)
Mar 13, 2025, 4:00 PM EDT - Market closed
Edgewise Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,407 | 2,528 | 694 | 565 | 753 | - | |
| Market Cap Growth | 264.15% | 264.15% | 22.85% | -24.97% | - | - | |
| Enterprise Value | 1,906 | 2,040 | 410 | 203 | 463 | - | |
| Last Close Price | 25.19 | 26.70 | 10.94 | 8.94 | 15.28 | - | |
| PB Ratio | 5.20 | 5.51 | 2.18 | 1.63 | 2.75 | - | |
| P/TBV Ratio | 5.51 | 5.51 | 2.18 | 1.63 | 2.75 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | - | - | |
| Quick Ratio | 19.71 | 19.71 | 18.98 | 21.22 | 26.69 | 29.73 | |
| Current Ratio | 19.93 | 19.93 | 19.50 | 21.53 | 26.97 | 29.86 | |
| Return on Equity (ROE) | -34.40% | -34.40% | -30.10% | -21.78% | -21.34% | -22.80% | |
| Return on Assets (ROA) | -24.01% | -24.01% | -20.21% | -13.73% | -12.97% | -13.80% | |
| Return on Capital (ROIC) | -25.19% | -25.19% | -21.17% | -14.32% | -13.46% | -14.31% | |
| Earnings Yield | -5.64% | -5.29% | -14.43% | -11.97% | -5.68% | - | |
| FCF Yield | -4.65% | -4.36% | -14.07% | -10.30% | -4.54% | - | |
| Buyback Yield / Dilution | -45.02% | -45.02% | -18.90% | -42.82% | -4977.96% | -95.63% | |
| Total Shareholder Return | -45.02% | -45.02% | -18.90% | -42.82% | -4977.96% | -95.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.